Item request has been placed!
×
Item request cannot be made.
×
Processing Request
COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Atherstone, Christine J.; Guagliardo, Sarah Anne J.; Hawksworth, Anthony; O’Laughlin, Kevin; Wong, Kimberly; Sloan, Michelle L.; Henao, Olga; Rao, Carol Y.; McElroy, Peter D.; Bennett, Sarah D.
- Source:
Emerging Infectious Diseases. Sep2023, Vol. 29 Issue 9, p1757-1764. 8p.
- Additional Information
- Subject Terms:
- Abstract:
The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policies) in 45 high-income countries during the Delta wave using rank-order correlation and ordinal regression. During the Delta-dominant period, most countries reported higher peak case rates (57%) and lower peak case-fatality rates (98%). Higher vaccination coverage was protective against peak case rates (odds ratio 0.95, 95% CI 0.91–0.99) and against peak death rates (odds ratio 0.96, 95% CI 0.91–0.99). Vaccination coverage was vital to preventing infection and death from COVID-19 during the Delta wave. As new variants emerge, public health authorities should encourage the uptake of COVID-19 vaccination and boosters. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.